SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
Hirohide Yoshikawa(Johns Hopkins University), James G. Herman(UPMC Hillman Cancer Center), Peta E. Jackson(Johns Hopkins University), John D. Groopman(Johns Hopkins University), Jasper Manning(Johns Hopkins University), Geng-Sun Qian(Shanghai Cancer Institute), Kenichi Matsubara(Nara Institute of Science and Technology), Curtis C. Harris(National Cancer Institute)
Cited by 734
Related Papers
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
Correlation of O<sup>6</sup>-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
|Journal of Clinical Oncology|2008|805
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
|The Lancet|1992|731